{"id":37991,"date":"2025-10-17T19:46:19","date_gmt":"2025-10-17T16:46:19","guid":{"rendered":"https:\/\/massivebio.com\/?p=37991"},"modified":"2025-10-17T19:46:19","modified_gmt":"2025-10-17T16:46:19","slug":"clinicaltrials-gov-shutdown","status":"publish","type":"post","link":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/","title":{"rendered":"Massive Bio Calls on Congress to Classify ClinicalTrials.gov as Essential Infrastructure Amid Government Shutdown"},"content":{"rendered":"

Boca Raton, FL – October 17, 2025<\/strong><\/p>\n

During the ongoing government shutdown, ClinicalTrials.gov<\/strong><\/a>, the nation\u2019s central registry for medical research and clinical studies, has gone offline, leaving millions of patients with cancer and other serious diseases unable to search for potentially life-saving clinical trials.<\/p>\n

“This should alarm every American,” said Dr. Arturo Loaiza-Bonilla<\/strong><\/a>, Co-Founder and Chief Medical & AI Officer of Massive Bio<\/a><\/strong>, a company recognized by the White House Cancer Moonshot initiative<\/a> <\/strong>for its leadership in expanding access to oncology clinical trials. “When ClinicalTrials.gov goes dark, hope goes dark for countless patients and families. This is not a luxury service – it\u2019s essential infrastructure for our nation\u2019s health.”<\/p>\n

Massive Bio stressed that access to clinical trials is fundamental to modern medicine. Disruptions in this access not only delay potential cures but also jeopardize years of research and erode public trust in science.<\/p>\n

“In times of crisis, technology should bridge gaps, not deepen them,” said Selin Kurnaz, PhD<\/strong><\/a>, Co-Founder and Chief Executive Officer of Massive Bio. “ClinicalTrials.gov is a beacon of hope and transparency for patients worldwide. Its availability should never be contingent on political negotiations. At Massive Bio, we remain steadfast in our mission to ensure that no patient is left behind – ever.”<\/p>\n

In response to the shutdown, Massive Bio has mobilized its AI-driven Synergy-AI<\/a><\/strong> trial matching platform and Patient Connect<\/a><\/strong> network to help patients continue finding and enrolling in trials free of charge. The company\u2019s multilingual care teams and technology infrastructure are ensuring uninterrupted support for patients and physicians globally.<\/p>\n

Massive Bio is calling on Congress to designate ClinicalTrials.gov as essential federal health infrastructure, protected from future shutdowns and political disruptions.<\/p>\n

“Access to clinical trials is not a privilege – it\u2019s a lifeline,” Dr. Loaiza-Bonilla concluded. “If Congress truly cares about the health of our nation, it must ensure this vital resource is permanently safeguarded.”<\/p>\n

About Massive Bio<\/strong>:<\/p>\n

Massive Bio, co-founded by Selin Kurnaz<\/strong><\/a>, Arturo Loaiza-Bonilla<\/strong><\/a>, and \u00c7a\u011fatay \u00c7ulcuo\u011flu<\/strong><\/a>, transforms the pharmaceutical value chain with AI-driven solutions. As an AI-enabled real-world data company, it streamlines the patient\u2019s journey, enhances access to advanced treatment options, and optimizes clinical trials. Massive Bio collaborates with pharmaceutical companies, research organizations, and healthcare institutions worldwide. A founding member of the CancerX public-private partnership and participant in the Cancer Moonshot White House initiative, the company has received recognition from the National Cancer Institute and operates across 17 countries with a global team of over 100 employees. For more information, visit www.massivebio.com<\/strong><\/a>.<\/p>\n

Media Contacts:<\/strong>
\nMassive Bio
\nMert Turkkan
\nMarketing Director
\nmturkkan@massivebio.com<\/strong><\/a><\/p>\n

<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"Boca Raton, FL – October 17, 2025 During the ongoing government shutdown, ClinicalTrials.gov, the nation\u2019s central registry for medical research and clinical studies, has gone offline, leaving millions of patients with cancer and other serious diseases unable to search for potentially life-saving clinical trials. “This should alarm every American,” said Dr. Arturo Loaiza-Bonilla, Co-Founder and...","protected":false},"author":11,"featured_media":37992,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-37991","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"\nMassive Bio Urges Congress to Protect ClinicalTrials.gov<\/title>\n<meta name=\"description\" content=\"Massive Bio urges Congress to classify ClinicalTrials.gov as essential infrastructure after the shutdown disrupts access for patients seeking trials.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Massive Bio Calls on Congress to Classify ClinicalTrials.gov as Essential Infrastructure Amid Government Shutdown %\" \/>\n<meta property=\"og:description\" content=\"Massive Bio urges Congress to classify ClinicalTrials.gov as essential infrastructure after the shutdown disrupts access for patients seeking trials.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-17T16:46:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/10\/PR_VISUAL-5.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1918\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Massive Bio Urges Congress to Protect ClinicalTrials.gov","description":"Massive Bio urges Congress to classify ClinicalTrials.gov as essential infrastructure after the shutdown disrupts access for patients seeking trials.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/","og_locale":"en_US","og_type":"article","og_title":"Massive Bio Calls on Congress to Classify ClinicalTrials.gov as Essential Infrastructure Amid Government Shutdown %","og_description":"Massive Bio urges Congress to classify ClinicalTrials.gov as essential infrastructure after the shutdown disrupts access for patients seeking trials.","og_url":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2025-10-17T16:46:19+00:00","og_image":[{"width":2560,"height":1918,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/10\/PR_VISUAL-5.webp","type":"image\/webp"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"Massive Bio Calls on Congress to Classify ClinicalTrials.gov as Essential Infrastructure Amid Government Shutdown","datePublished":"2025-10-17T16:46:19+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/"},"wordCount":458,"commentCount":34,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/10\/PR_VISUAL-5.webp","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/","url":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/","name":"Massive Bio Urges Congress to Protect ClinicalTrials.gov","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/10\/PR_VISUAL-5.webp","datePublished":"2025-10-17T16:46:19+00:00","description":"Massive Bio urges Congress to classify ClinicalTrials.gov as essential infrastructure after the shutdown disrupts access for patients seeking trials.","breadcrumb":{"@id":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/10\/PR_VISUAL-5.webp","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/10\/PR_VISUAL-5.webp","width":2560,"height":1918,"caption":"Massive Bio Calls on Congress to Classify ClinicalTrials.gov as Essential Infrastructure Amid Government Shutdown"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/clinicaltrials-gov-shutdown\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/massivebio.com\/resources\/news-en\/"},{"@type":"ListItem","position":3,"name":"Massive Bio Calls on Congress to Classify ClinicalTrials.gov as Essential Infrastructure Amid Government Shutdown"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists & Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/37991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=37991"}],"version-history":[{"count":2,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/37991\/revisions"}],"predecessor-version":[{"id":37994,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/37991\/revisions\/37994"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/37992"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=37991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=37991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=37991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}